propionylcarnitine has been researched along with Disease Models, Animal in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgartner, MR; Burda, P; Devuyst, O; Fingerhut, R; Forny, P; Froese, DS; Heeren, J; Hornemann, T; Kölker, S; Langhans, CD; Mathis, D; Mustedanagic, M; Nägele, N; Peters, HL; Scheja, L; Schumann, A; Thony, B; Wulf, MA; Zhakupova, A | 1 |
| Alvarez de Sotomayor, M; Dolores Herrera, M; Gonzalez del Pozo, M; Mingorance, C | 1 |
| Arcuri, G; Borsini, F; De Falco, S; Lombardo, K; Marcellini, M; Mattera, GG; Orlandi, A; Pisano, C; Riccioni, T; Scioli, MG; Spagnoli, LG; Stasi, MA | 1 |
| Apstein, CS; Brenner, DA; Koh, SG; Korzick, DH; Saupe, KW; Tickerhoof, MM | 1 |
| Dhalla, NS; Ferrari, R; Sethi, R; Wang, X | 1 |
| Al-Majed, AA; Al-Rejaie, SS; Al-Shabanah, OA; Al-Yahya, AA; Aleisa, AM; Sayed-Ahmed, MM | 1 |
| Al-Majed, AA; Al-Omar, FA; Al-Shabanah, OA; Al-Yahya, AA; Aleisa, AM; Sayed-Ahmed, MM | 1 |
| Al-Majed, AA | 1 |
| Di Lascio, A; Ferlosio, A; Francesconi, A; Marcellini, M; Orlandi, A; Pisano, C; Spagnoli, LG | 1 |
| De Angelis, C; Marino, B; Mauriello, A; Orlandi, A; Ramacci, MT; Spagnoli, LG | 1 |
| Arrigoni Martelli, E; Aureli, T; Conti, F; Corsico, N; Di Cocco, ME; Lucreziotti, MR; Miccheli, A; Nardone, A; Pesce, D; Spagnoli, LG | 1 |
| Anversa, P; Bianchi, G; Ceppi, E; Cinato, E; Conti, F; Ferrari, P; Torielli, L | 1 |
| Arrigoni-Martelli, E; Corsico, N; Mancinelli, R; Manni, E; Maresca, P | 1 |
| De Giuli, F; Ferrari, R | 1 |
| Calvani, M; Marcellini, M; Orlandi, A; Pesce, D; Spagnoli, LG | 1 |
1 review(s) available for propionylcarnitine and Disease Models, Animal
| Article | Year |
|---|---|
The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.
Topics: Animals; Cardiotonic Agents; Carnitine; Chronic Disease; Disease Models, Animal; Heart; Heart Failure; Humans; Models, Biological; Muscles; Rabbits; Rats | 1997 |
14 other study(ies) available for propionylcarnitine and Disease Models, Animal
| Article | Year |
|---|---|
Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect.
Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Biomarkers; Brain; Carnitine; Dietary Proteins; Disease Models, Animal; Gene Dosage; Gene Knock-In Techniques; Kidney; Methylmalonic Acid; Methylmalonyl-CoA Mutase; Mice; Mice, Knockout; Phenotype; Quantitative Trait, Heritable | 2016 |
Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
Topics: Animals; Carnitine; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Endothelium, Vascular; Glucose Tolerance Test; Hemodynamics; Hyperinsulinism; Insulin Resistance; Lipids; Metabolic Syndrome; Obesity; Rats; Rats, Zucker; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Weight Gain | 2009 |
Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Vessels; Carnitine; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Collateral Circulation; Disease Models, Animal; Endothelium, Vascular; Hindlimb; Humans; Intercellular Adhesion Molecule-1; Ischemia; Mice; NADPH Oxidase 4; NADPH Oxidases; Neovascularization, Physiologic; Rabbits; Regional Blood Flow; Superoxides; Vascular Endothelial Growth Factor A | 2010 |
Exercise intolerance during post-MI heart failure in rats: prevention with supplemental dietary propionyl-L-carnitine.
Topics: Animals; Carnitine; Diet; Disease Models, Animal; Exercise Tolerance; Heart Failure; In Vitro Techniques; Myocardial Infarction; Rats; Rats, Inbred F344; Tissue Distribution; Ventricular Function, Left | 2003 |
Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Carnitine; Disease Models, Animal; Enzyme Activation; GTP-Binding Proteins; Heart Failure; Isoproterenol; Male; Models, Cardiovascular; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Signal Transduction; Stroke Volume; Ventricular Function | 2004 |
Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Carnitine; Cisplatin; Disease Models, Animal; Glutathione; Heart; Male; Myocardium; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2006 |
Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus.
Topics: Acetylcarnitine; Adenosine Triphosphate; Animals; Carnitine; Disease Models, Animal; Energy Metabolism; Glutathione; Hippocampus; Ischemic Attack, Transient; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitrates; Nitrites; Oxidative Stress; Prosencephalon; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2006 |
Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats.
Topics: Adenosine Triphosphate; Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carnitine; Chemical and Drug Induced Liver Injury; Cisplatin; Disease Models, Animal; gamma-Glutamyltransferase; Glutathione; Liver; Liver Function Tests; Male; Nitrates; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Risk Factors; Thiobarbituric Acid Reactive Substances; Vitamin B Deficiency | 2007 |
Propionyl-L-carnitine prevents age-related myocardial remodeling in the rabbit.
Topics: Aging; Animals; Cardiotonic Agents; Carnitine; Collagen; Collagen Type I; Disease Models, Animal; Endomyocardial Fibrosis; Fibroblasts; Immunohistochemistry; In Situ Nick-End Labeling; Male; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Vascular Cell Adhesion Molecule-1; Ventricular Remodeling | 2007 |
Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits.
Topics: Aging; Animals; Arteriosclerosis; Carnitine; Cell Division; Diet; Disease Models, Animal; Female; Foam Cells; Hyperlipidemias; Immunohistochemistry; Lipoproteins, VLDL; Male; Muscle, Smooth, Vascular; Rabbits | 1995 |
Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: a functional, histologic, and NMR spectroscopic study.
Topics: Animals; Cardiotonic Agents; Carnitine; Disease Models, Animal; Energy Metabolism; Femoral Artery; Hindlimb; Magnetic Resonance Spectroscopy; Male; Muscles; Peripheral Vascular Diseases; Rats; Rats, Wistar | 1993 |
Alterations in energy metabolism of hypertrophied rat cardiomyocytes: influence of propionyl-L-carnitine.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Cardiotonic Agents; Carnitine; Cell Size; Disease Models, Animal; Energy Metabolism; Fatty Acids; Glucose; Heart; Heart Ventricles; In Vitro Techniques; Male; Myocardium; Oxidation-Reduction; Palmitates; Phosphocreatine; Rats; Rats, Inbred WKY | 1995 |
Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy.
Topics: Administration, Oral; Analysis of Variance; Animals; Biomechanical Phenomena; Cardiomyopathy, Dilated; Cardiotonic Agents; Carnitine; Cricetinae; Disease Models, Animal; Genetic Diseases, Inborn; Male; Mesocricetus; Myocardial Contraction; Papillary Muscles | 1995 |
Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biomarkers; Carnitine; Carotid Arteries; Caspase 3; Caspases; Cholesterol; Disease Models, Animal; Extracellular Matrix; Hyperplasia; Male; Muscle, Smooth, Vascular; Rabbits; Triglycerides; Tunica Intima | 2002 |